Bristol-Myers
Squibb Company (NYSE: BMY) will host a teleconference on Sunday,
October 9, 2016, at 7:30 p.m. CEST (1:30 p.m. EDT) to discuss data
presented at the European Society of Medical Oncology (ESMO) 2016
Congress in Copenhagen, Denmark. Company executives will provide an
overview of data presented at the meeting, with a focus on the company’s
Immuno-Oncology portfolio, and address inquiries from investors and
analysts.
Investors and the general public are invited to listen to a live webcast
of the call at: investor.bms.com,
by dialing toll free (877) 258-2708 or international (647) 252-4456,
confirmation code: 74677318. Materials related to the call will be
available at the same website prior to the call. A replay of the call
will be available beginning at 4:30 p.m. EDT on October 9, 2016 through
11:59 p.m. EDT on October 16. The replay can be accessed at investor.bms.com or
by dialing (855) 859-2056 or (404) 537-3406, confirmation code: 74677318.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
Bristol-Myers Squibb Media:Ken Dominski, 609-252-5251, ken.dominski@bms.com or Investors:Tim Power, 609-252-7509, timothy.power@bms.com Bill Szablewski, 609-252-5894, william.szablewski@bms.com